Magna

Uhnder Inc. is a technology company focused on developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in California, with engineering and operations in Austin and St. Louis, Uhnder specializes in a digital automotive radar-on-chip. This technology offers a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, which are commonly used in autonomous vehicles. The radar-on-chip enhances safety by helping to avoid collisions, providing alerts for potential issues, and enabling quick localization through electronic navigation fences. By improving feedback response and system automation, Uhnder aims to transform the autonomous vehicle landscape.

Uhnder Inc. is a technology company focused on developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in California, with engineering and operations in Austin and St. Louis, Uhnder specializes in a digital automotive radar-on-chip. This technology offers a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, which are commonly used in autonomous vehicles. The radar-on-chip enhances safety by helping to avoid collisions, providing alerts for potential issues, and enabling quick localization through electronic navigation fences. By improving feedback response and system automation, Uhnder aims to transform the autonomous vehicle landscape.

Frontier Diamonds Limited is involved in diamond exploration and development in South Africa, holding a 74% interest in the Sedibeng diamond mine and a 100% interest in the Star diamond mine. The Sedibeng mine, located in the Northern Cape, consists of two licenses covering 89.62 hectares, while the Star mine, situated in the Free State, encompasses a single license over 246.29 hectares. Established in 2016 and based in Melbourne, Australia, Frontier Diamonds focuses on optimizing operations and enhancing efficiency at these mines, which have shown profitability and positive cash flow over the past two years. The company aims to leverage its expertise in engineering and underground mining to improve productivity and is exploring additional opportunities to expand its footprint in the diamond industry. With both mines expected to sustain operations for at least 15 years, Frontier Diamonds is positioned to become a significant producer of high-quality diamonds.

Zubie is a connected vehicle services company that offers a platform designed to deliver essential vehicle health, location, and safety information to both consumers and businesses. By utilizing a plug-in device known as the Zubie Key, users can easily access and monitor their vehicle data through mobile applications available for iOS and Android. The service provides insights into fuel efficiency, location tracking, and driving behavior, which helps businesses enhance vehicle maintenance, prevent accidents, and optimize fleet operations. Zubie's subscription model includes the Zubie Key, mobile apps, and an online web portal, catering to the needs of both individual consumers and commercial fleets.

Bioheart, Inc. is dedicated to advancing the field of regenerative medicine by offering the highest quality technology, cellular treatments and training. Specific to biotechnology, Bioheart, Inc. specializes in the discovery, development and commercialization of autologous cellular therapies that treat a wide variety of degenerative diseases. Bioheart, Inc. is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry by delivering stem cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions, chronic and acute heart damage, peripheral vascular disease and other issues. Bioheart's goals are to improve a patient’s quality of life by regenerating their damaged tissue, when possible, and by reducing health care costs and hospitalizations. Bioheart’s leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.

SINTX Technologies, Inc. is a biomaterial company specializing in the research, development, manufacturing, and commercialization of medical implant products made from silicon nitride. Founded in 1996 and headquartered in Salt Lake City, Utah, SINTX offers a range of ceramic-based biomaterial solutions applicable in various medical and industrial fields. The company primarily focuses on producing spinal implant products, marketed under the Valeo brand, which are used in cervical and thoracolumbar surgeries. SINTX operates an ISO 13485 certified manufacturing facility and collaborates with external partners, providing custom manufacturing and development of silicon nitride ceramics for both medical and non-medical applications. Its products are recognized for their biocompatibility, bioactivity, and excellent bone affinity, and have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.